Pancreatic Cancer Research

ResearcherCity of HopeNo recent work listed

Ravi Salgia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9643-7626; OpenAlex author ID A5003826371. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 0, last author 3)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 trials · 2022: 1 paper

Papers 6

  1. Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215801↗
  2. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma. Last author DOI 10.1080/15384047.2017.1416937↗
  3. Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade. Last author DOI 10.1186/s40169-018-0210-9↗
  4. Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer. Co-author DOI 10.3892/ol.2017.5956↗
  5. FAK and paxillin, two potential targets in pancreatic cancer. Last author DOI 10.18632/oncotarget.8040↗
  6. Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. Co-author DOI 10.1200/jco.2015.62.8719↗

Trials 2

  1. Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer Principal investigator NCT04158635↗
  2. A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations Principal investigator NCT05163028↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 3 shared papers, 2016–2022 · strength 0.29
  2. Vincent M. Chung · 2 shared papers, 2018–2022 · strength 0.22
  3. Rajani Kanteti · 2 shared papers, 2016–2018 · strength 0.15
  4. Jesse L. Cox · 1 shared paper, 2022 · strength 0.13
  5. Suprit Gupta · 1 shared paper, 2022 · strength 0.13
  6. Shailendra Kumar Gautam · 1 shared paper, 2022 · strength 0.13
  7. Maneesh Jain · 1 shared paper, 2022 · strength 0.13
  8. Satyanarayana Rachagani · 1 shared paper, 2022 · strength 0.13
  9. Hedy Lee Kindler · 2 shared papers, 2015–2018 · strength 0.11
  10. Elizabeth C. Little · 1 shared paper, 2017 · strength 0.09
  11. Deborah Lang · 1 shared paper, 2017 · strength 0.09
  12. Paul J. Grippo · 1 shared paper, 2017 · strength 0.09
  13. Daneng Li · 1 shared paper, 2018 · strength 0.09
  14. Andrew Eugene Hendifar · 1 shared paper, 2018 · strength 0.09
  15. May Thet Cho · 1 shared paper, 2018 · strength 0.09
  16. Richard Tuli · 1 shared paper, 2018 · strength 0.09
  17. Jun Gong · 1 shared paper, 2018 · strength 0.09
  18. Parthasarathy Seshacharyulu · 1 shared paper, 2018 · strength 0.07
  19. Garima Kaushik · 1 shared paper, 2018 · strength 0.07
  20. Moorthy Palanimuthu Ponnusamy · 1 shared paper, 2018 · strength 0.07
  21. Deirdre Jill Cohen · 1 shared paper, 2015 · strength 0.04
  22. Robert Marsh · 1 shared paper, 2015 · strength 0.04
  23. Heinz‐Josef Lenz · 1 shared paper, 2015 · strength 0.04
  24. Melissa R. Junttila · 1 shared paper, 2015 · strength 0.04
  25. Daniel V.T. Catenacci · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.